Benocyclidine
From Self-sufficiency
File:BTCP structure.png | |
Systematic (IUPAC) name | |
---|---|
1-[1-(1-benzothiophen-2-yl)cyclohexyl]piperidine | |
Identifiers | |
CAS Number | 112726-66-6 |
ATC code | none |
PubChem | CID 123692 |
Chemical data | |
Formula | C19H25NS |
Molar mass | 299.474 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
Benocyclidine (BCP), or benzothiophenylcyclohexylpiperidine (BTCP), is a psychoactive drug and research chemical of the arylcyclohexylamine and piperidine chemical classes. It acts a potent and selective dopamine reuptake inhibitor (DRI) and is therefore a stimulant.[1][2] Unlike related compounds like phencyclidine and ketamine, benocyclidine is a pure DRI with negligible affinity for the NMDA receptor, and it therefore lacks any anticonvulsant, anesthetic, hallucinogenic, or dissociative effects.[1][2] It has been used to label the dopamine transporter.[3][4]
BCP was also used to try and find a common pharmacophore for DRI type stimulants.[5]
See also
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
This pharmacology-related article is a stub. You can help ssf by expanding it. |
- ↑ 1.0 1.1 Vignon J, Pinet V, Cerruti C, Kamenka JM, Chicheportiche R. (1998). "[3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP): a new phencyclidine analog selective for the dopamine uptake complex". Eur J Pharmacol. 148 (3): 427–436. doi:10.1016/0014-2999(88)90122-7. PMID 3384005.
- ↑ 2.0 2.1 Chaudieu I, Vignon J, Chicheportiche M, Kamenka JM, Trouiller G, Chicheportiche R. (1989). "Role of the aromatic group in the inhibition of phencyclidine binding and dopamine uptake by PCP analogs". Pharmacol Biochem Behav. 32 (3): 699–705. doi:10.1016/0091-3057(89)90020-8. PMID 2544905.
- ↑ Filloux F, Hunt MA, Wamsley JK. (1989). "Localization of the dopamine uptake complex using [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP) in rat brain". Neurosci Lett. 100 (1-3): 105–110. doi:10.1016/0304-3940(89)90668-X. PMID 2527343.
- ↑ Maurice T, Vignon J, Kamenka JM, Chicheportiche R. (1989). "In vivo labelling of the mouse dopamine uptake complex with the phencyclidine derivative [3H]BTCP". Neurosci Lett. 101 (2): 234–238. doi:10.1016/0304-3940(89)90537-5. PMID 2771169.
- ↑ Froimowitz M, Wu KM, Rodrigo J, George C (2000). "Conformational preferences of the potent dopamine reuptake blocker BTCP and its analogs and their incorporation into a pharmacophore model". J Comput Aided Mol Des. 14 (2): 135–46. doi:10.1023/A:1008144707255. PMID 10721502.
Categories:
- Pages with script errors
- Pages using duplicate arguments in template calls
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Stimulants
- Piperidines
- Benzothiophenes
- Pharmacology stubs
- 2Fix
- CS1 maint: Multiple names: authors list